Document is current
Any future updates will be listed below
-
Authors
Radke, David I. https://orcid.org/0009-0005-9189-5747
Bogatsch, Holger
Engel, Christoph https://orcid.org/0000-0002-7247-282X
Bloos, Frank https://orcid.org/0000-0002-0767-7941
Meybohm, Patrick https://orcid.org/0000-0002-2666-8696
Bauer, Michael https://orcid.org/0000-0002-1521-3514
Homayr, Anna Lulu
Stoppe, Christian https://orcid.org/0000-0002-2028-2039
Elke, Gunnar https://orcid.org/0000-0002-4948-1605
Lindner, Matthias https://orcid.org/0000-0003-2647-7790
,
Nierhaus, Axel
Briegel, Josef
Jaschinski, Ulrich
Mörer, Onnen
Weyland, Andreas
Gründling, Matthias
Kluge, Stefan
Utzolino, Stefan
Stehr, Sebastian
Ragaller, Maximilian
Brunkhorst, Frank
Gerlach, Herwig
-
Funding
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
- License Information
-
More Information
Article History
Received: 28 November 2024
Accepted: 27 March 2025
First Online: 14 April 2025
Declarations
:
: The study protocol of the SISPCT trial was approved by the ethics board of Jena University Hospital (Internal File No. 2242-03/08). Written informed consent was obtained from all patients or their legal representatives.
: Not applicable. No individual participant data is reported that would require consent to publish from the participant.
: All authors have provided information on potential conflicts of interests directly or indirectly related to the work submitted in the journal’s disclosure forms. FB reported receiving lecture honoraria from biosyn, Gilead, and CSL Behring and public funding for the SISPCT trial to his department by the German Federal Ministry of Education and Research and unrestricted research grants for the SISPCT trial from biosyn and Thermo Fisher Scientific. CS received honorarium as speaker and/or consultant for Fresenius, Baxter and BBRAUN. GE received honorarium as speaker and/or consultant for Fresenius. All other authors declared that they have no conflict of interest.
